Summary
NRPS is a microbial enzymatic system that constructs complex peptides without mRNA templates or ribosomes. Modular megasynthetases follow a colinear logic where module order determines peptide sequence.
Key Points
- 1No mRNA template—enzyme modules specify sequence
- 2A domain selects amino acids; T domain carries them; C domain forms bonds
- 3Can incorporate non-proteinogenic amino acids and D-isomers
- 4Produces penicillin, vancomycin, cyclosporine, and many other drugs
Non-ribosomal peptide synthesis represents an alternative paradigm for peptide assembly, producing many of our most important natural product drugs.
Overview
NRPS produces peptides without:
Instead, large megasynthetase enzymes directly specify and assemble the peptide sequence.
Modular Architecture
NRPS enzymes are organized into modules, each responsible for one amino acid:
Core Domains
Adenylation (A) Domain
Thiolation (T) / Peptidyl Carrier Protein (PCP) Domain
- Uses phosphopantetheine arm as tether
Condensation (C) Domain
Accessory Domains
- Epimerization (E): Converts L to D amino acids
- Methylation (M): N- or C-methylation
- Cyclization (Cy): Forms heterocyclic rings
- Oxidation (Ox): Oxidizes thiazoline to thiazole
Termination
Thioesterase (TE) Domain
The Colinearity Rule
A key principle: the order of modules in the megasynthetase directly determines the sequence of the peptide product.
This modularity makes NRPS:
Chemical Diversity
NRPS produces remarkable chemical diversity:
Non-proteinogenic substrates:
Modifications:
Important NRPS Products
Many critical drugs are NRPS products:
- Penicillin: β-lactam antibiotic
- Vancomycin: Glycopeptide antibiotic
- Cyclosporine: Immunosuppressant
- Daptomycin: Lipopeptide antibiotic
- Bleomycin: Anticancer agent